| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 49 | 2024 | 16184 | 2.260 |
Why?
|
| Receptor, ErbB-2 | 39 | 2017 | 2648 | 1.790 |
Why?
|
| 14-3-3 Proteins | 4 | 2016 | 143 | 1.770 |
Why?
|
| Brain Neoplasms | 11 | 2024 | 4982 | 1.630 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2022 | 263 | 1.350 |
Why?
|
| Tumor Microenvironment | 9 | 2023 | 2984 | 1.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2017 | 2093 | 1.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 29 | 2024 | 9078 | 1.090 |
Why?
|
| src-Family Kinases | 3 | 2015 | 487 | 1.090 |
Why?
|
| Transforming Growth Factor beta | 3 | 2022 | 1133 | 1.020 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2024 | 39 | 0.960 |
Why?
|
| Quinazolines | 7 | 2016 | 953 | 0.930 |
Why?
|
| Cell Transformation, Neoplastic | 16 | 2020 | 2471 | 0.930 |
Why?
|
| Drug Resistance, Neoplasm | 13 | 2021 | 5411 | 0.920 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2017 | 135 | 0.920 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 247 | 0.880 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 2 | 2013 | 28 | 0.850 |
Why?
|
| Neoplasm Metastasis | 17 | 2017 | 5324 | 0.800 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2022 | 116 | 0.780 |
Why?
|
| Adenovirus E1A Proteins | 11 | 2007 | 165 | 0.780 |
Why?
|
| Histamine | 1 | 2021 | 60 | 0.780 |
Why?
|
| Integrin beta1 | 1 | 2022 | 134 | 0.780 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 163 | 0.760 |
Why?
|
| Mice | 63 | 2024 | 35996 | 0.760 |
Why?
|
| Immunotherapy | 6 | 2022 | 3533 | 0.760 |
Why?
|
| Astrocytes | 1 | 2024 | 405 | 0.750 |
Why?
|
| Animals | 79 | 2024 | 62871 | 0.740 |
Why?
|
| Cell Line, Tumor | 30 | 2024 | 14864 | 0.740 |
Why?
|
| Neoplasms | 14 | 2024 | 15838 | 0.740 |
Why?
|
| Antineoplastic Agents | 15 | 2022 | 14678 | 0.700 |
Why?
|
| Genes, erbB-2 | 7 | 2001 | 228 | 0.700 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 143 | 0.630 |
Why?
|
| ErbB Receptors | 8 | 2015 | 2379 | 0.630 |
Why?
|
| Antibodies, Monoclonal | 9 | 2022 | 4511 | 0.610 |
Why?
|
| Signal Transduction | 15 | 2022 | 12207 | 0.610 |
Why?
|
| Trastuzumab | 11 | 2017 | 736 | 0.600 |
Why?
|
| Protein Kinase Inhibitors | 9 | 2017 | 4956 | 0.600 |
Why?
|
| Bone Neoplasms | 4 | 2022 | 2668 | 0.600 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2016 | 317 | 0.570 |
Why?
|
| Neoplasms, Experimental | 5 | 2017 | 791 | 0.570 |
Why?
|
| Cancer Vaccines | 2 | 2022 | 750 | 0.570 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2017 | 557 | 0.560 |
Why?
|
| B7-H1 Antigen | 6 | 2022 | 1057 | 0.550 |
Why?
|
| Neuregulin-1 | 3 | 2001 | 89 | 0.540 |
Why?
|
| Proto-Oncogene Proteins | 11 | 1999 | 2618 | 0.540 |
Why?
|
| Exosomes | 1 | 2019 | 252 | 0.540 |
Why?
|
| Genetic Therapy | 11 | 2007 | 1732 | 0.500 |
Why?
|
| Breast | 5 | 2017 | 1364 | 0.490 |
Why?
|
| Paclitaxel | 9 | 2001 | 2099 | 0.490 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2015 | 1725 | 0.490 |
Why?
|
| Phosphorylation | 14 | 2022 | 4986 | 0.480 |
Why?
|
| Triple Negative Breast Neoplasms | 3 | 2022 | 1347 | 0.480 |
Why?
|
| Antibodies, Monoclonal, Humanized | 10 | 2014 | 3398 | 0.470 |
Why?
|
| Tumor Escape | 3 | 2024 | 248 | 0.470 |
Why?
|
| Up-Regulation | 8 | 2016 | 2465 | 0.470 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 203 | 0.460 |
Why?
|
| Genes, myc | 1 | 2015 | 373 | 0.450 |
Why?
|
| Humans | 100 | 2024 | 271076 | 0.450 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2015 | 280 | 0.430 |
Why?
|
| PTEN Phosphohydrolase | 5 | 2014 | 1014 | 0.430 |
Why?
|
| Genes, p53 | 7 | 2011 | 1135 | 0.420 |
Why?
|
| Tumor Cells, Cultured | 27 | 2017 | 5835 | 0.410 |
Why?
|
| Female | 58 | 2024 | 148608 | 0.390 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2015 | 1571 | 0.390 |
Why?
|
| Mice, Nude | 15 | 2021 | 4360 | 0.380 |
Why?
|
| Protein Kinase C-alpha | 2 | 2014 | 68 | 0.380 |
Why?
|
| Adenoviridae | 6 | 2007 | 1510 | 0.370 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2019 | 3657 | 0.370 |
Why?
|
| Enzyme Activation | 8 | 2012 | 1837 | 0.360 |
Why?
|
| RNA, Long Noncoding | 3 | 2023 | 618 | 0.350 |
Why?
|
| Transfection | 18 | 2001 | 3172 | 0.340 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 673 | 0.330 |
Why?
|
| T-Lymphocytes | 4 | 2023 | 3929 | 0.330 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2001 | 687 | 0.330 |
Why?
|
| Mice, Transgenic | 7 | 2017 | 4370 | 0.320 |
Why?
|
| Genes, ras | 2 | 2014 | 680 | 0.320 |
Why?
|
| Blood-Brain Barrier | 2 | 2023 | 247 | 0.300 |
Why?
|
| Proteomics | 2 | 2021 | 1435 | 0.290 |
Why?
|
| Apoptosis | 12 | 2017 | 7852 | 0.290 |
Why?
|
| Gene Expression | 10 | 2020 | 3682 | 0.290 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2399 | 0.280 |
Why?
|
| Genetic Vectors | 6 | 2007 | 1884 | 0.280 |
Why?
|
| Neoplasm Proteins | 6 | 2021 | 3349 | 0.270 |
Why?
|
| Lung Neoplasms | 9 | 2019 | 11758 | 0.270 |
Why?
|
| Antineoplastic Agents, Phytogenic | 4 | 2001 | 896 | 0.270 |
Why?
|
| Neoplasm Transplantation | 10 | 2021 | 1567 | 0.260 |
Why?
|
| Glycolysis | 3 | 2016 | 534 | 0.260 |
Why?
|
| Dendritic Cells | 3 | 2022 | 1108 | 0.260 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2006 | 99 | 0.260 |
Why?
|
| Cell Line | 12 | 2021 | 5439 | 0.260 |
Why?
|
| Cell Proliferation | 10 | 2023 | 7295 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 7 | 2019 | 4067 | 0.250 |
Why?
|
| Neoplastic Stem Cells | 4 | 2021 | 1469 | 0.250 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2024 | 1010 | 0.240 |
Why?
|
| Hepatitis A Virus Cellular Receptor 2 | 2 | 2022 | 58 | 0.230 |
Why?
|
| Immune Evasion | 1 | 2024 | 76 | 0.230 |
Why?
|
| Brain | 4 | 2023 | 4256 | 0.230 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 1654 | 0.220 |
Why?
|
| RNA, Small Nucleolar | 1 | 2023 | 25 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 3459 | 0.220 |
Why?
|
| NF-kappa B | 4 | 2019 | 1583 | 0.220 |
Why?
|
| Endothelial Growth Factors | 2 | 2001 | 237 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2022 | 3919 | 0.220 |
Why?
|
| Oncogene Proteins, Viral | 3 | 2001 | 147 | 0.220 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 902 | 0.220 |
Why?
|
| Lymphokines | 2 | 2001 | 319 | 0.220 |
Why?
|
| Transcription, Genetic | 5 | 2000 | 3417 | 0.220 |
Why?
|
| Lipolysis | 1 | 2023 | 108 | 0.210 |
Why?
|
| Sarcoma | 6 | 2001 | 1840 | 0.210 |
Why?
|
| Receptors, Estrogen | 3 | 2017 | 2264 | 0.210 |
Why?
|
| Kynurenine | 1 | 2023 | 67 | 0.210 |
Why?
|
| Carrier Proteins | 3 | 2019 | 2126 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2022 | 58 | 0.210 |
Why?
|
| Cell Movement | 5 | 2022 | 2500 | 0.210 |
Why?
|
| Oncogenes | 2 | 2019 | 700 | 0.200 |
Why?
|
| Cyclin-Dependent Kinase 9 | 1 | 2022 | 66 | 0.200 |
Why?
|
| Receptors, Eph Family | 1 | 2022 | 32 | 0.200 |
Why?
|
| Soft Tissue Neoplasms | 3 | 2001 | 920 | 0.200 |
Why?
|
| Receptors, Histamine | 1 | 2021 | 8 | 0.200 |
Why?
|
| Vitamin E | 1 | 2022 | 131 | 0.200 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2023 | 304 | 0.200 |
Why?
|
| Casein Kinase II | 1 | 2022 | 60 | 0.200 |
Why?
|
| CDC2 Protein Kinase | 2 | 2001 | 183 | 0.200 |
Why?
|
| Programmed Cell Death 1 Receptor | 4 | 2022 | 1088 | 0.200 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 2214 | 0.200 |
Why?
|
| Carcinogenesis | 2 | 2021 | 1030 | 0.200 |
Why?
|
| Ephrin-A4 | 1 | 2021 | 7 | 0.190 |
Why?
|
| Point Mutation | 3 | 2000 | 791 | 0.190 |
Why?
|
| Disease Progression | 5 | 2019 | 6896 | 0.190 |
Why?
|
| Leiomyosarcoma | 4 | 2000 | 255 | 0.190 |
Why?
|
| Cyclin B1 | 2 | 2017 | 60 | 0.190 |
Why?
|
| Proto-Oncogenes | 2 | 1992 | 208 | 0.190 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2021 | 58 | 0.190 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2021 | 19 | 0.190 |
Why?
|
| Extracellular Matrix | 1 | 2023 | 534 | 0.180 |
Why?
|
| DNA Fingerprinting | 1 | 2021 | 181 | 0.180 |
Why?
|
| Galectins | 1 | 2021 | 73 | 0.180 |
Why?
|
| Myocarditis | 1 | 2022 | 195 | 0.180 |
Why?
|
| Immunity, Innate | 2 | 2024 | 688 | 0.180 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2001 | 351 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 429 | 0.180 |
Why?
|
| Nitrogen | 1 | 2020 | 181 | 0.170 |
Why?
|
| RNA, Neoplasm | 3 | 2017 | 811 | 0.170 |
Why?
|
| DNA Replication | 1 | 2024 | 772 | 0.170 |
Why?
|
| Integrins | 1 | 2021 | 277 | 0.170 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 496 | 0.170 |
Why?
|
| Cyclin-Dependent Kinases | 2 | 1998 | 323 | 0.170 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 1215 | 0.170 |
Why?
|
| Immunohistochemistry | 8 | 2022 | 7816 | 0.170 |
Why?
|
| Killer Cells, Natural | 2 | 2023 | 958 | 0.170 |
Why?
|
| Ovarian Neoplasms | 7 | 2017 | 4774 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 2021 | 425 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2014 | 527 | 0.160 |
Why?
|
| Drug Resistance, Multiple | 2 | 1996 | 221 | 0.160 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 7464 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 224 | 0.150 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1998 | 132 | 0.150 |
Why?
|
| Antigen Presentation | 1 | 2019 | 289 | 0.150 |
Why?
|
| Heterografts | 2 | 2021 | 745 | 0.150 |
Why?
|
| HEK293 Cells | 4 | 2021 | 1473 | 0.150 |
Why?
|
| Genes, p16 | 1 | 1998 | 131 | 0.150 |
Why?
|
| Gene Targeting | 2 | 1998 | 321 | 0.150 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 45 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 7 | 2015 | 3245 | 0.150 |
Why?
|
| Adenoviruses, Human | 4 | 2000 | 191 | 0.150 |
Why?
|
| Protein Array Analysis | 3 | 2021 | 505 | 0.140 |
Why?
|
| Cells, Cultured | 4 | 2013 | 5784 | 0.140 |
Why?
|
| Genes, Retinoblastoma | 2 | 1994 | 93 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2021 | 685 | 0.140 |
Why?
|
| Cyclins | 1 | 1998 | 470 | 0.140 |
Why?
|
| Down-Regulation | 6 | 2014 | 2109 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2001 | 887 | 0.140 |
Why?
|
| Injections | 1 | 2017 | 289 | 0.130 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2021 | 1021 | 0.130 |
Why?
|
| Transcription Factors | 4 | 2020 | 5494 | 0.130 |
Why?
|
| Protein Binding | 4 | 2021 | 3537 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2014 | 505 | 0.130 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2021 | 1158 | 0.130 |
Why?
|
| Benzodioxoles | 1 | 2015 | 29 | 0.130 |
Why?
|
| Isoenzymes | 2 | 2016 | 666 | 0.130 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 759 | 0.130 |
Why?
|
| Indazoles | 1 | 2017 | 310 | 0.130 |
Why?
|
| Neutrophils | 1 | 2020 | 870 | 0.130 |
Why?
|
| Retinoblastoma Protein | 2 | 1998 | 342 | 0.130 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2015 | 30 | 0.130 |
Why?
|
| Glycoproteins | 1 | 1999 | 797 | 0.130 |
Why?
|
| Macrophages | 1 | 2021 | 1369 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 2474 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2001 | 1119 | 0.120 |
Why?
|
| Peptide Hydrolases | 1 | 2016 | 265 | 0.120 |
Why?
|
| Cell Cycle | 3 | 2013 | 2151 | 0.120 |
Why?
|
| Smad Proteins | 1 | 2015 | 82 | 0.120 |
Why?
|
| Sirtuins | 1 | 2014 | 43 | 0.120 |
Why?
|
| Taxoids | 1 | 1998 | 1008 | 0.120 |
Why?
|
| Stem Cells | 2 | 2011 | 1229 | 0.120 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2017 | 698 | 0.120 |
Why?
|
| Genes, Viral | 2 | 1997 | 257 | 0.110 |
Why?
|
| Ubiquitination | 4 | 2019 | 577 | 0.110 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2015 | 193 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 1885 | 0.110 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2013 | 360 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2014 | 137 | 0.110 |
Why?
|
| Mutation | 9 | 2014 | 15855 | 0.110 |
Why?
|
| Cell Growth Processes | 1 | 2013 | 339 | 0.110 |
Why?
|
| Imidazoles | 2 | 2014 | 1060 | 0.110 |
Why?
|
| Electric Impedance | 1 | 2013 | 101 | 0.110 |
Why?
|
| Mice, SCID | 5 | 2021 | 1856 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 1618 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2017 | 753 | 0.110 |
Why?
|
| Ribonucleosides | 1 | 2012 | 36 | 0.110 |
Why?
|
| Histones | 1 | 2020 | 1510 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 1437 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2013 | 272 | 0.100 |
Why?
|
| Protein Biosynthesis | 2 | 2015 | 1037 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2012 | 1604 | 0.100 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2012 | 53 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 1995 | 812 | 0.100 |
Why?
|
| Sarcoma, Experimental | 3 | 2007 | 68 | 0.100 |
Why?
|
| F-Box Proteins | 1 | 2012 | 99 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2015 | 1004 | 0.100 |
Why?
|
| Glucose | 2 | 2015 | 1255 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 2 | 2023 | 5233 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 3866 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2012 | 229 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2023 | 1817 | 0.100 |
Why?
|
| Transcriptional Activation | 4 | 2009 | 1147 | 0.100 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2011 | 704 | 0.090 |
Why?
|
| Cell Division | 8 | 2000 | 2718 | 0.090 |
Why?
|
| Transglutaminases | 1 | 2011 | 100 | 0.090 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2013 | 237 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 1294 | 0.090 |
Why?
|
| Transplantation, Heterologous | 6 | 2013 | 1089 | 0.090 |
Why?
|
| Quinolines | 1 | 2014 | 402 | 0.090 |
Why?
|
| Tyrosine | 3 | 2022 | 510 | 0.090 |
Why?
|
| Glioblastoma | 1 | 2021 | 1776 | 0.090 |
Why?
|
| DNA-Binding Proteins | 4 | 2009 | 5042 | 0.090 |
Why?
|
| Adenocarcinoma | 3 | 2021 | 7938 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2011 | 185 | 0.090 |
Why?
|
| Receptor, trkB | 1 | 2010 | 53 | 0.090 |
Why?
|
| Genomics | 1 | 2021 | 2817 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 348 | 0.090 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2001 | 350 | 0.090 |
Why?
|
| MCF-7 Cells | 3 | 2017 | 553 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2011 | 917 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2013 | 3649 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 658 | 0.080 |
Why?
|
| Disease-Free Survival | 2 | 2019 | 10250 | 0.080 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2009 | 72 | 0.080 |
Why?
|
| 3T3 Cells | 5 | 2001 | 388 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2012 | 1369 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6249 | 0.080 |
Why?
|
| In Situ Hybridization | 1 | 2010 | 1062 | 0.080 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2010 | 530 | 0.080 |
Why?
|
| Models, Biological | 2 | 2011 | 3227 | 0.080 |
Why?
|
| Indoles | 2 | 2006 | 1035 | 0.080 |
Why?
|
| CTLA-4 Antigen | 1 | 2012 | 667 | 0.080 |
Why?
|
| Phosphoproteins | 2 | 2011 | 1229 | 0.080 |
Why?
|
| Glycosylation | 2 | 2020 | 231 | 0.080 |
Why?
|
| Sulfonamides | 1 | 2017 | 1922 | 0.080 |
Why?
|
| Interferon-gamma | 1 | 2012 | 1184 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2011 | 2906 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2011 | 16592 | 0.080 |
Why?
|
| Mesoderm | 1 | 2010 | 397 | 0.080 |
Why?
|
| Cell Survival | 4 | 2022 | 3082 | 0.070 |
Why?
|
| Prognosis | 4 | 2016 | 22463 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 3 | 2021 | 1084 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2011 | 5838 | 0.070 |
Why?
|
| Chemotaxis | 3 | 2010 | 142 | 0.070 |
Why?
|
| RNA Interference | 1 | 2011 | 1398 | 0.070 |
Why?
|
| Sirolimus | 1 | 2011 | 833 | 0.070 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 635 | 0.070 |
Why?
|
| Recombinant Proteins | 4 | 2001 | 3076 | 0.070 |
Why?
|
| Carcinoma, Lobular | 1 | 2010 | 617 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2002 | 1742 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2011 | 5568 | 0.070 |
Why?
|
| Biomarkers, Tumor | 4 | 2016 | 10698 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2010 | 1887 | 0.070 |
Why?
|
| Base Sequence | 3 | 2021 | 5500 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 1019 | 0.060 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 108 | 0.060 |
Why?
|
| Carbazoles | 1 | 2006 | 92 | 0.060 |
Why?
|
| Protein Stability | 2 | 2016 | 374 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 5161 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2023 | 1735 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2013 | 1178 | 0.060 |
Why?
|
| Tumor Stem Cell Assay | 2 | 1997 | 233 | 0.060 |
Why?
|
| Cisplatin | 2 | 2011 | 2493 | 0.060 |
Why?
|
| Head and Neck Neoplasms | 2 | 2011 | 4124 | 0.060 |
Why?
|
| Molecular Sequence Data | 4 | 1997 | 6792 | 0.060 |
Why?
|
| Oncolytic Virotherapy | 1 | 2007 | 235 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 1645 | 0.060 |
Why?
|
| MRE11 Homologue Protein | 1 | 2024 | 37 | 0.060 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2024 | 56 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 251 | 0.060 |
Why?
|
| Rad51 Recombinase | 1 | 2024 | 125 | 0.060 |
Why?
|
| Rejuvenation | 1 | 2023 | 23 | 0.060 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2010 | 1233 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 2 | 2001 | 1599 | 0.060 |
Why?
|
| Gelatinases | 2 | 1993 | 53 | 0.060 |
Why?
|
| Ribonucleases | 1 | 2023 | 99 | 0.060 |
Why?
|
| Liposomes | 2 | 1995 | 713 | 0.050 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2022 | 37 | 0.050 |
Why?
|
| Nerve Growth Factors | 1 | 2022 | 129 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 1990 | 1726 | 0.050 |
Why?
|
| Adaptive Immunity | 1 | 2023 | 149 | 0.050 |
Why?
|
| Interleukin-15 | 1 | 2023 | 189 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 912 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2010 | 4968 | 0.050 |
Why?
|
| Antineoplastic Agents, Immunological | 2 | 2022 | 1335 | 0.050 |
Why?
|
| Estrogen Receptor beta | 1 | 2022 | 168 | 0.050 |
Why?
|
| DNA | 3 | 2024 | 3076 | 0.050 |
Why?
|
| Genes, MDR | 1 | 2001 | 42 | 0.050 |
Why?
|
| DNA Fragmentation | 2 | 1998 | 208 | 0.050 |
Why?
|
| Drug Resistance | 2 | 2000 | 616 | 0.050 |
Why?
|
| Adipocytes | 1 | 2023 | 308 | 0.050 |
Why?
|
| AC133 Antigen | 1 | 2021 | 109 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 54 | 0.050 |
Why?
|
| Adenovirus Early Proteins | 2 | 1991 | 12 | 0.050 |
Why?
|
| Survival Rate | 2 | 2014 | 12519 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2022 | 324 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2024 | 522 | 0.050 |
Why?
|
| Flavonoids | 1 | 2001 | 201 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2021 | 319 | 0.040 |
Why?
|
| Rats | 5 | 2007 | 6661 | 0.040 |
Why?
|
| RNA, Messenger | 5 | 2001 | 6492 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2001 | 420 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2021 | 270 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2007 | 3082 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2001 | 388 | 0.040 |
Why?
|
| Cell Aggregation | 1 | 1999 | 62 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2021 | 9309 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 1994 | 5516 | 0.040 |
Why?
|
| Kinetin | 1 | 1998 | 4 | 0.040 |
Why?
|
| Sarcoma, Synovial | 1 | 2000 | 130 | 0.040 |
Why?
|
| Plasmids | 2 | 1992 | 952 | 0.040 |
Why?
|
| I-kappa B Proteins | 1 | 1999 | 178 | 0.040 |
Why?
|
| Estradiol | 1 | 2022 | 885 | 0.040 |
Why?
|
| Glutathione Transferase | 2 | 2011 | 368 | 0.040 |
Why?
|
| Cyclin B | 1 | 1998 | 69 | 0.040 |
Why?
|
| Receptor, ErbB-3 | 1 | 1999 | 126 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 385 | 0.040 |
Why?
|
| Phenotype | 4 | 2014 | 6465 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 280 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 259 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2022 | 513 | 0.040 |
Why?
|
| Antibodies | 1 | 2021 | 837 | 0.040 |
Why?
|
| Tretinoin | 1 | 2000 | 621 | 0.040 |
Why?
|
| U937 Cells | 1 | 2017 | 179 | 0.040 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1998 | 258 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2017 | 260 | 0.040 |
Why?
|
| Fibrosarcoma | 1 | 1997 | 141 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2022 | 879 | 0.040 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 705 | 0.040 |
Why?
|
| Collagenases | 1 | 1997 | 75 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1998 | 253 | 0.040 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2017 | 171 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1998 | 540 | 0.040 |
Why?
|
| Caspases | 1 | 2000 | 701 | 0.040 |
Why?
|
| Purines | 1 | 1998 | 279 | 0.040 |
Why?
|
| Cross Reactions | 1 | 1997 | 269 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 1998 | 212 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 2 | 1997 | 139 | 0.040 |
Why?
|
| Temperature | 1 | 1998 | 542 | 0.040 |
Why?
|
| COP9 Signalosome Complex | 1 | 2016 | 80 | 0.030 |
Why?
|
| Vaccines, Subunit | 1 | 2017 | 127 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 1997 | 246 | 0.030 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2016 | 40 | 0.030 |
Why?
|
| Doxorubicin | 2 | 2001 | 3138 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1997 | 148 | 0.030 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1997 | 181 | 0.030 |
Why?
|
| Immunologic Surveillance | 1 | 2016 | 61 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2021 | 715 | 0.030 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2016 | 162 | 0.030 |
Why?
|
| Curcumin | 1 | 2016 | 119 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 487 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2014 | 1719 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 1997 | 885 | 0.030 |
Why?
|
| Fibroblasts | 2 | 1998 | 1669 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1995 | 135 | 0.030 |
Why?
|
| Epitopes | 1 | 1997 | 711 | 0.030 |
Why?
|
| Telomerase | 1 | 1998 | 533 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 2016 | 445 | 0.030 |
Why?
|
| Pyridines | 1 | 2001 | 1312 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 1538 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1997 | 1046 | 0.030 |
Why?
|
| Adenoma | 1 | 2019 | 741 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 1986 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2000 | 1655 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 235 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 1509 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 1997 | 4646 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2001 | 5183 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2010 | 4787 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2006 | 3667 | 0.030 |
Why?
|
| Pepsin A | 1 | 1992 | 15 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2013 | 155 | 0.030 |
Why?
|
| Gene Amplification | 2 | 1993 | 769 | 0.030 |
Why?
|
| beta-Galactosidase | 2 | 2007 | 278 | 0.030 |
Why?
|
| Proteins | 1 | 2001 | 2049 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 474 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 2125 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1992 | 41 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 390 | 0.030 |
Why?
|
| Organelles | 1 | 2002 | 46 | 0.020 |
Why?
|
| Male | 7 | 2022 | 128555 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 22062 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 90070 | 0.020 |
Why?
|
| Cell Nucleolus | 1 | 2011 | 102 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 1992 | 174 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 213 | 0.020 |
Why?
|
| Entosis | 1 | 2011 | 4 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2011 | 94 | 0.020 |
Why?
|
| Kisspeptins | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2014 | 834 | 0.020 |
Why?
|
| CD24 Antigen | 1 | 2011 | 88 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 1502 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2011 | 71 | 0.020 |
Why?
|
| Actins | 2 | 2007 | 615 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 5107 | 0.020 |
Why?
|
| Cytokinesis | 1 | 2011 | 57 | 0.020 |
Why?
|
| Salvage Therapy | 2 | 2011 | 2117 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 457 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2013 | 452 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2940 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 524 | 0.020 |
Why?
|
| Hyaluronan Receptors | 1 | 2011 | 250 | 0.020 |
Why?
|
| Oxamic Acid | 1 | 2009 | 2 | 0.020 |
Why?
|
| RNA | 2 | 2011 | 1069 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1992 | 503 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2011 | 378 | 0.020 |
Why?
|
| Protein Transport | 1 | 2002 | 738 | 0.020 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2009 | 44 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 671 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2011 | 4191 | 0.020 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2009 | 63 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2009 | 110 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2009 | 125 | 0.020 |
Why?
|
| Everolimus | 1 | 2011 | 438 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2010 | 171 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 1997 | 2044 | 0.020 |
Why?
|
| Virus Replication | 2 | 2007 | 761 | 0.020 |
Why?
|
| Mitosis | 1 | 2011 | 690 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 414 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2011 | 782 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 1263 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2000 | 831 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 644 | 0.020 |
Why?
|
| Biological Transport | 1 | 2009 | 659 | 0.020 |
Why?
|
| Aged | 2 | 2011 | 73177 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2011 | 706 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 594 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2009 | 312 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 2007 | 23 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1997 | 6165 | 0.020 |
Why?
|
| Adult | 2 | 2011 | 81614 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 1061 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2013 | 1260 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2021 | 33833 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2001 | 736 | 0.020 |
Why?
|
| Perfusion | 1 | 2007 | 290 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 1708 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 298 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1547 | 0.020 |
Why?
|
| Extremities | 1 | 2007 | 307 | 0.020 |
Why?
|
| United States | 1 | 2022 | 15989 | 0.020 |
Why?
|
| Oxygen | 1 | 2009 | 800 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2007 | 704 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 1997 | 431 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 4840 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2013 | 2198 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2000 | 1666 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1990 | 1836 | 0.010 |
Why?
|
| Carcinogenicity Tests | 1 | 2001 | 69 | 0.010 |
Why?
|
| Cdc20 Proteins | 1 | 2001 | 27 | 0.010 |
Why?
|
| Microscopy, Video | 1 | 2000 | 31 | 0.010 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2000 | 35 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 2000 | 120 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 4182 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2000 | 164 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 2000 | 166 | 0.010 |
Why?
|
| Survival | 1 | 2000 | 184 | 0.010 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 1999 | 138 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 462 | 0.010 |
Why?
|
| Connective Tissue Cells | 1 | 1998 | 9 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2000 | 483 | 0.010 |
Why?
|
| Connective Tissue | 1 | 1998 | 37 | 0.010 |
Why?
|
| Rats, Nude | 1 | 1997 | 28 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 542 | 0.010 |
Why?
|
| Technetium | 1 | 1997 | 80 | 0.010 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2001 | 621 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1997 | 238 | 0.010 |
Why?
|
| Femoral Vein | 1 | 1997 | 64 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 7784 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1997 | 203 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1998 | 751 | 0.010 |
Why?
|
| beta Catenin | 1 | 2000 | 690 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1997 | 658 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2000 | 815 | 0.010 |
Why?
|
| Binding Sites | 1 | 2000 | 2309 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2006 | 2953 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1995 | 125 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2001 | 2490 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 909 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1995 | 1757 | 0.010 |
Why?
|
| Moloney murine sarcoma virus | 1 | 1992 | 10 | 0.010 |
Why?
|
| Oncogene Proteins v-mos | 1 | 1992 | 18 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 335 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 424 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 1312 | 0.010 |
Why?
|
| China | 1 | 1992 | 638 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1992 | 1460 | 0.010 |
Why?
|
| Liver | 1 | 1998 | 3127 | 0.000 |
Why?
|
| Lung | 1 | 1998 | 3268 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1998 | 7218 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 15256 | 0.000 |
Why?
|
| Kidney | 1 | 1992 | 2339 | 0.000 |
Why?
|